The top 20 Cardiology Business stories for February 2022

Dave Fornell | | Cardiovascular Business | Heart Health
Top cardiology stories in Cardiology Business magazine in February 2022. The top stories this month included new information on COVID vaccine caused myocarditis and the FDA clearance of the first transcatheter dual-chamber leadless pacemaker system from Abbott.

The top stories this month included new information on COVID vaccine-caused myocarditis and the FDA clearance of the first transcatheter dual-chamber leadless pacemaker system from Abbott.

These were the most popular stories on Cardiology Business in February 2022:

1. Caffeine, energy drinks and other natural supplements can cause heart damage, cardiologists warn

2. Cardiac MRI sheds new light on COVID vaccine-related myocarditis

3. Heart drug trimetazidine at center of Olympics controversy surrounding figure skater Kamila Valieva

4. Late-breaking clinical trials announced for ACC.22

5. First implant of dual-chamber leadless pacemaker completed in Abbott’s Aveir DR i2i pivotal trial

6. Long-term risk of heart attack, coronary artery disease or stroke much higher among COVID-19 patients

7. 4 new medications and technologies that could transform cardiology in 2022

8. FDA approves empagliflozin for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

9. Hospital pays $3.8M to resolve allegations it assisted cardiologist in exchange for patient referrals

10. Plant-based diets boost cardiovascular health, lower risk of severe COVID-19

 

11. Cardiologist dies after small plane crash in Minnesota

12. Additional lots of losartan recalled due to potential cancer risk

13. Implantable atrial shunt therapy trial identifies treatable HFpEF patients

14. Metformin boosts outcomes for patients with HF and diabetes—sulfonylurea initiation makes things worse

15. Medtronic recalls a second directional atherectomy device due to risk of tip damage

16. HeartFlow calls off plans to merge, go public due to ‘unfavorable market conditions’

17. Recovered COVID-19 patients face higher risk of heart rate abnormalities, type 2 diabetes

18. Same-day discharge after LAAO is safe, cost-effective and ‘could become the new standard’

19. Abbott implantable heart failure monitor gains expanded FDA approval

20. Boston Scientific finalizes acquisition of Baylis Medical with $1.75B payment
 

Related top news stories content:

Most popular stories in Radiology Business from February 2022

The top 20 Health Executive stories for February 2022

Top Health Imaging stories in February 2022

 

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.
Dave Fornell

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com

Related Content

FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders
Merck spends up to $2B to license new weight loss drug with potential heart benefits
‘A significant step forward’: Advocates cheer as heart health bill passes Senate
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Genetic predisposition to depression increases CVD risk in women, but not men
Eating more plant-based protein reduces risk of heart disease

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.